To characterize the local immune landscape in cervical cancer, we performed immunohistochemical analysis on nine tumor biopsies, assessing the expression and spatial distribution of key immune markers (Supplementary Figure S6): CD8, PD-1, PD-L1, and TIGIT. The gene discussed is CD8A; the disease is cervical carcinoma.